Studies

Mirza MR, Bjørge L, Marmé F, Christensen RD, Gil-Martin M, Auranen A, Ataseven B, Rubio MJ, Salutari V, Luczak AA, Runnebaum IB, Redondo A, Lindemann K, Trillsch F, Ginesta MPB, Roed H, Kurtz JE, Petersson KS, Nyvang GB, Sehouli J (2024)
Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial
Gynecol Oncol, 192, 128-136 (in press)
DOI 10.1016/j.ygyno.2024.12.003, PubMed 39657575

Areklett EW, Hagen BI, Stubberud J, Fagereng E, Andersson S, Lindemann K (2024)
Digital goal management training for cognitive impairment in cervical cancer survivors-a randomized comparison study
J Cancer Surviv (in press)
DOI 10.1007/s11764-024-01701-4, PubMed 39576570

Kleppe A, Lindemann K, Kildal W, Tobin KAR, Pradhan M, Vlatkovic L, Isaksen MX, Danielsen HE, Askautrud HA, Kristensen GB (2024)
Prognostic and therapeutic implication of molecular classification including L1CAM expression in high-risk endometrial cancer
Gynecol Oncol, 192, 80-88 (in press)
DOI 10.1016/j.ygyno.2024.11.005, PubMed 39549540